Hats off to the growing tribe of edupreneurs for offering quality education in India (The Advent of Edupreneurs, BT cover, September 20). Thanks to them we are witnessing capital-intensive, new schools, colleges and professional education institutes come up despite the travails of the licence-permit Raj in the education sector.
Avnish Thakur, Delhi
The nation’s moribund, moth-eaten education system fashioned by Lord Macaulay over a century ago needs an urgent makeover. But Indian edupreneurs wanting to set up high-quality campuses have felt thwarted by the HRD Ministry’s Licence Raj. Though there’s consensus within India’s academic community for revamping our education system, the draft Foreign Universities Bill only ensures that no decent foreign university will enter India.
Given the demand for higher—especially professional—study programmes, a new genre of edupreneurs are rising to the challenge of providing internationally benchmarked institutions of higher learning. The S.P. Jain Institute of Management and Narsee Monjee Institute of Management in Mumbai; Amity University, Delhi; ISB and ICFAI, Hyderabad; Mahavir Academy of Technical Sciences and Presidency College, Bangalore and the Great Lakes Institute of Management, Chennai are among the better-known ones.
Garima Pandey, Patna
I’m an avid reader of your magazine and find your Jargonbuster very helpful in clearing misconceptions regarding contemporary businessspeak and management terms. However, I think that including just one such term in the Jargonbuster series is a bit too less for attracting serious attention or for the readers to actually notice it with appreciation and look forward to it the next edition. Why not amplify this section?
Nitin Garg, Delhi
With reference to our story on the instances of US MNCs being penalised in the US for “unreported” payments made in India (Warning for the Bribe Tribe, BT, August 23), The Dow Chemical Company has clarified that it was not found “guilty” or charged with any crime under the Foreign Corrupt Practices Act.
I agree with your views in 67% Market Share But Still Insecure (BT, August 9) that GSK India should focus on niche categories than make a play for mass-market products. However, I wonder why GSK has left its Viva brand to languish? It could try repositioning it in the MFD segment as a nutritional supplement. But Horlicks remains GSK’s mother brand and money puller and the company should not lose focus of its star brand by mindless line extensions of other products.
B. Chandrashekaran, Chennai